Related Experiment Video
Updated: Jul 22, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Applying decision analysis to pharmacy management and practice decisions
1Bouve College of Pharmacy and Health Sciences, Northeastern University, Boston, MA.
Topics in Hospital Pharmacy Management
|December 9, 1993
Summary
Decision analysis offers a structured, quantitative method for making management decisions. This approach helps evaluate actions, consequences, and uncertainties for optimal outcomes in pharmacy settings.
Area of Science:
- Decision Science
- Management Science
- Health Economics
Background:
- Decision analysis provides a structured framework for complex decision-making.
- It involves explicit, quantitative, and prescriptive methods for choosing among alternatives.
- This analytical viewpoint is crucial in various management and healthcare scenarios.
Purpose of the Study:
- To present decision analysis as a structured approach to decision making.
- To illustrate its application in a typical management situation.
- To provide pharmacy-related literature examples of decision analysis.
Main Methods:
- Defining decision analysis as an explicit, quantitative, and prescriptive approach.
- Structuring courses of action and their consequences.
- Assessing uncertainty and valuing preferences for outcomes.
Main Results:
- Decision analysis engenders an analytical viewpoint in decision-makers.
- It facilitates the structuring of actions, consequences, uncertainty, and preferences.
- Literature examples demonstrate its utility in pharmacy and health policy.
Conclusions:
- Decision analysis is a valuable tool for informed decision-making in management.
- Its application in pharmacy, covering formulary additions to health policy, highlights its versatility.
- The approach supports evidence-based choices by quantifying risks and preferences.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).